Trial intelligence / Profile preview

MAGIC Cell-3-DES: G-CSF and Stem Cell Infusion in Myocardial Infarction

NCT00291629Phase 2Completed

Sponsor
Seoul National University Hospital
Start
Mar 2004
Modality
Cytokines & Interferons, Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of peripheral blood stem cells, filgrastim in myocardial infarction (MI), sponsored by Seoul National University Hospital. Started Mar 2004; status: completed.

02

Drugs

peripheral blood stem cellsfilgrastim
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT00291629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00291629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call